Control group:Routine basic treatment

2 trials

Sponsors

Shandong Second Provincial General Hospital

Conditions

mild Cognitive impairment in cerebral Small Vessel Disease (the De-CSVD study)

Phase 4

The effects of Dengyin Naotong in patients with mild cognitive impairment in cerebral Small Vessel Disease (the De-CSVD study): a multicentre randomized controlled trial

RecruitingITMCTR2100004786

Shandong Second Provincial General Hospitalmild Cognitive impairment in cerebral Small Vessel Disease (the De-CSVD study)

Start: 2021-05-10Updated: 2023-02-20

The effects of Dengyin Naotong in patients with mild cognitive impairment in cerebral Small Vessel Disease (the De-CSVD study): a multicentre randomized controlled trial

RecruitingChiCTR2100045831

Shandong Second Provincial General Hospitalmild Cognitive impairment in cerebral Small Vessel Disease (the De-CSVD study)

Start: 2021-05-10Updated: 2021-12-13

Related Papers

Efficacy and safety of Dengyinnaotong Capsule in patients with Cognitive impairment caused by cerebral Small Vessel Disease: study protocol of a multicenter, randomized, open-label, controlled trial (De-CSVD trial).

2022-08-172 citations